Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026827 (
hypotonia
)
5,860
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We report on two siblings, a boy and a girl, with agenesis of corpus callosum and neuronopathy. The children show diffuse
hypotonia
, delayed motor and mental development. Neurophysiological examinations revealed reduction of the motor nerve conduction velocity, absence of sensory nerve action potentials, abnormal somatosensory and visual evoked potentials. Nerve biopsies showed reduced density of myelinated and unmyelinated fibres in both children. We also found signs of hypomyelination and suggest this is secondary to degeneration of peripheral sensory and motor neurons. Our findings are consistent with the diagnosis of
Andermann syndrome
. This is the first report of the occurrence of
Andermann syndrome
out of French Canada.
...
PMID:Occurrence of Andermann syndrome out of French Canada--agenesis of the corpus callosum with neuronopathy. 823 87
Andermann syndrome
, otherwise known as agenesis of the corpus callosum with peripheral neuropathy (ACCPN), is an autosomal recessive motor and sensory neuropathy known to be associated with ACC and mild-to-moderate intellectual disability. We present a 7-year-old girl with infantile-onset
hypotonia
, mild intellectual disability, and severe motor and sensory demyelinating peripheral neuropathy. Brain magnetic resonance imaging showed intact corpus callosum. Whole exome sequencing showed a novel splice-site pathogenic variant in the
SLC12A6
gene. We confirm that ACC is not a mandatory feature and suggest that the term ACCPN may be misleading.
...
PMID:A Novel Splice-Site Variant in
SLC12A6
Causes Andermann Syndrome without Agenesis of the Corpus Callosum. 3276 36